BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $699,756 | +5.9% | 15,359 | -5.7% | 0.03% | -7.1% |
| Q1 2023 | $660,844 | -94.1% | 16,293 | -92.5% | 0.03% | -95.8% |
| Q4 2022 | $11,146,578 | +69.5% | 218,689 | +113.5% | 0.67% | +178.0% |
| Q2 2022 | $6,578,000 | -44.3% | 102,415 | -32.8% | 0.24% | -47.8% |
| Q1 2022 | $11,810,000 | +1881.5% | 152,307 | +2093.4% | 0.46% | +1611.1% |
| Q4 2021 | $596,000 | -85.9% | 6,944 | -86.8% | 0.03% | -90.1% |
| Q2 2021 | $4,233,000 | +1325.3% | 52,590 | +1394.9% | 0.27% | +1713.3% |
| Q1 2021 | $297,000 | -90.6% | 3,518 | -91.0% | 0.02% | -89.0% |
| Q4 2020 | $3,146,000 | -49.5% | 39,206 | -49.4% | 0.14% | -53.4% |
| Q3 2020 | $6,233,000 | +256.8% | 77,501 | +281.9% | 0.29% | +228.1% |
| Q2 2020 | $1,747,000 | -5.1% | 20,295 | -10.5% | 0.09% | -33.1% |
| Q1 2020 | $1,841,000 | -43.8% | 22,671 | -42.2% | 0.13% | -7.6% |
| Q4 2019 | $3,278,000 | +947.3% | 39,200 | +995.0% | 0.14% | +800.0% |
| Q3 2019 | $313,000 | -93.4% | 3,580 | -95.4% | 0.02% | -96.2% |
| Q2 2017 | $4,722,000 | +113.6% | 77,998 | +68.0% | 0.42% | +84.8% |
| Q3 2016 | $2,211,000 | +45.4% | 46,440 | +0.3% | 0.23% | +76.9% |
| Q3 2015 | $1,521,000 | -33.1% | 46,301 | +39.6% | 0.13% | -57.0% |
| Q1 2015 | $2,272,000 | – | 33,172 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |